News

Novo Nordisk’s Wegovy approved as UK’s first daily GLP-1 weight loss pill

Jun 12, 2026 | News, Regulatory

The tablets will be available as a once-daily treatment, an alternative to weekly injections for adults with obesity, or overweight with a weight-related condition

Roche’s Tecentriq gets FDA Priority Review for specific stage 3 colon cancer

Jun 11, 2026 | News, Regulatory

Over one million people are diagnosed globally each year and around 30% of stage 3 patients relapse within five years

Lilly’s Ebglyss approved by FDA as maintenance dose for atopic dermatitis

Jun 10, 2026 | News, Regulatory

This new option for patients allows for as few as six maintenance injections per year

GSK to acquire biopharma Nuvalent for $10.6bn

Jun 9, 2026 | News, Research

Two of Nuvalent’s NSCLC therapies have received FDA Breakthrough Therapy and Orphan Drug Designations

CSL’s Privigen approved as measles treatment by European Commission

Jun 9, 2026 | News, Regulatory

Cases of measles have been rising in Europe since 2023

Roche and Nurix Therapeutics to partner in $2.3bn deal

Jun 8, 2026 | News, Research

The companies will co-develop and co-commercialise bexobrutideg across malignant haematology, immunology and neurology

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA

Jun 5, 2026 | News, Regulatory

In the study, there were improvements in motor function as well as a slowing of neurodegeneration

Alnylam and Inceptive agree on $2bn AI collaboration

Jun 4, 2026 | News, Research

The deal will assist accelerate the discovery of RNAi therapeutics

Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate

Jun 3, 2026 | News, Research

The drug showed improvements in overall survival and progression-free survival in two cancers

J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis

Jun 2, 2026 | News, Research

Erleada plus hormone therapy significantly improved key short- and long-term clinical outcomes

Pfizer and Innovent Biologics agree on deal worth up to $10.5bn

Jun 1, 2026 | News, Research

The companies plan to research and develop 12 new cancer treatments

EMA celebrates diversity and inclusion in science and healthcare

Jun 1, 2026 | News, Healthcare

The EU body underlines its commitment to diverse perspectives in medicines regulation

Novo Nordisk’s Wegovy approved as UK’s first daily GLP-1 weight loss pill

Roche’s Tecentriq gets FDA Priority Review for specific stage 3 colon cancer

Lilly’s Ebglyss approved by FDA as maintenance dose for atopic dermatitis

GSK to acquire biopharma Nuvalent for $10.6bn

CSL’s Privigen approved as measles treatment by European Commission

Roche and Nurix Therapeutics to partner in $2.3bn deal

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA

Alnylam and Inceptive agree on $2bn AI collaboration

Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate

J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis

Pfizer and Innovent Biologics agree on deal worth up to $10.5bn

EMA celebrates diversity and inclusion in science and healthcare

Latest content

Latest intelligence

Quick links